The theme for ACannabis 2023 was Growing The Industry Through Research, Collaboration and Innovation. Dive back in to any session with our video library.

Session List – Day 1

• Session 1 – Opening & Welcome
• Session 2 – Trends and opportunities for medical cannabis
• Session 3 – Future trends in medicinal cannabis regulation around the globe
• Session 4 – In conversation with the Australian regulators
• Session 5 – Positioning the medicinal cannabis sector for success
• Session 6 – Future state of TGO 93 Panel: An in-depth look at the TGO 93 changes that are effective 1 July 2023 with particular focus on GMP Import changes and are importers ready?
• Session 7 – Navigating medicinal cannabis challenges
• Session 8 – Fireside chat with Dr Richard Di Natale, Reflections on Australia’s medicinal cannabis journey, role of evidence/education in expanding access and future directions
• Session 9 – Emerging researchers showcase
• Session 10 – Closing Comments Day 1

Session List – Day 2

• Session 11 – Welcome & Keynote address
• Session 12 – Industry and market outlook
• Session 13 – Partnering for success in the medicinal cannabis industry
• Session 14 – Best-practices for medicinal cannabis prescribers & new education tools for healthcare practitioners
• Session 15 – Keynote address – John Easterling, Launch of the Olivia Newton-John Service to Industry Award
• Session 16 – Showcasing R&D and innovation – from plant to patient
• Session 17 – Fireside chat with Cameron Scadding, How to achieve success while being ethical & legitimate
• Session 18 – Wrap Up & Closing Comments

Supplementary Video

• Dr Kerryn Phelps, Hemp CRC: Role of evidence in expanding access to medicinal cannabis and building sustainable industries

Speaker Presentations – Day 1

Session 1 – Opening & Welcome

MC: Nathan Davis, Executive Director, MedReleaf Australia

MCIA Chair, Mr Peter Crock and
The Hon Ged Kearney MP, Federal Member for Cooper, Assistant Minister for Health and Aged Care

Back to top

Session 2 – Trends and opportunities for medical cannabis 

Trends and international opportunities for medicinal cannabis and cannabinoid development. Session sponsored by ARC Research Hub for Medicinal Agriculture.

Moderator

• Peter Crock, Chair, MCIA

Keynote

• Hunter Land, Vice President, Translational Research, Biopharmaceutical Research Company

Back to top

Session 3 – Future trends in medicinal cannabis regulation around the globe

A look at what’s happening in cannabis regulation in key countries

Moderator

• Rosemary Richards, MCIA

Panellists

• Sally King, Executive Director, New Zealand Medicinal Cannabis Council
• Martin Woodbridge, Advisor, Bedrocan
• Jacob Vogel, Syqe

Back to top

Session 4 – In conversation with the Australian regulators

Fireside Chat around the Australian regulatory landscape, future changes with

Moderator

• Donna Edman, Astute Advocacy

Panellists

• Adjunct Professor Robyn Langham, Chief Medical Advisor, TGA and
• Danielle Chifley, Director, Medicinal Cannabis, ODC

Back to top

Session 5 – Positioning the medicinal cannabis sector for success

Moderator

• Jo Patterson, CEO, BOD Australia and MCIA Director

Panellists

• Patty Holmes, Holmes Wilson
• Peter Koetsier, CEO, Cann Group
• Tim Evans, Private Client Adviser, Morgans Financial Limited
• Oliver Zugel, Founder and CEO, FoliuMed

Back to top

Session 6 – Future state of TGO 93 Panel

An in-depth look at the TGO 93 changes that are effective 1 July 2023 with particular focus on GMP Import changes and are importers ready?

Moderator

• Patty Holmes, Director, Holmes and Wilson

Panellists

• Jenny Burnett, Assistant Secretary – Manufacturing Quality Branch (MQB), Department of Health & Aged Care
• Steve Notaro, Head of Legal and Regulatory Affairs, Cann Group
• Gordon Chan, Quality Operations and Regulatory Affairs , MedReleaf Australia
• Clare Barker, Consultant
• Oliver Zugel, Founder and CEO, FoliuMed

Back to top

Session 7 – Navigating medicinal cannabis challenges

A series of presentations from industry leaders

Moderator

• Rosemary Richards, MCIA

Presenters

• Adam Benjamin, CEO, Standard Botanic
  The size of the opportunity for new Australian cannabis cultivators is almost exceeded by the size of the hurdles
• Kyle Hunt, CEO and Founder, Health Care Providers Association
  Obtaining a medicinal cannabis license and maintaining SOP’s
• Nick Owen, Founder and CEO, Nucleotrace
  A new platform for securing cannabis supply chains

Back to top

Session 8 – Fireside chat with Dr Richard Di Natale

Moderator

• Martin Lane, Co Founder, Cannabiz

Speaker

• Dr Richard Di Natale
  Reflections on Australia’s medicinal cannabis journey, role of evidence/education in expanding access and future directions

Back to top

Session 9 – Emerging researchers showcase

Moderators

• Professor Iain McGregor, Professor of Psychopharmacology & Academic Director – Lambert Initiative for Cannabinoid Therapeutics, University of Sydney
• Dr Veronica Borrett, Senior Director, ARC Research Hub for Medicinal Agriculture

Presenters

• Laura Steel, ARC MedAG Hub, La Trobe University
  The investigation of flowering time in cannabis sativa
• Dr Cilla Zhou, Lambert Initiative, University of Sydney
  Surveys and recruitment strategies at the Lambert Initiative
• John Laws, University of Adelaide
  The neurological bioactivity of cannabis prevalent terpenes: implications for medical cannabis formulations
  Dr Llew Mills, Discipline of Addiction Medicine, University of Sydney
  The cannabis as medicine surveys (CAMS): The evolution of medical cannabis use in Australia following deregulation
• Matthew Nolan, Southern Cross University
  Cannabis sativa, a model species for glandular trichome research
  Dr Danielle McCartney, Lambert Initiative, University of Sydney
  The effects of CBD and THC on cognitive function and driving performance
• Dr Mulu Oli, ARC MedAG Hub, La Trobe University
  Towards genomics-assisted improvement of glandular trichome productivity in Cannabis sativa
• Dr Adam Ametovski, Lambert Initiative, University of Sydney
  Cannabinoid synthesis: An overview of the medicinal chemistry program at The Lambert Initiative
• Dr Martin O’Brien, ARC MedAG Hub, La Trobe University
  The Use of tissue culture into a commercial production line, the “hows” to get there
• Dr Anastasia Suraev, Lambert Initiative, University of Sydney
  Emerging insights into the role of cannabinoids in sleep

Back to top

Session 10 – Closing Comments Day 1

Back to top

Speaker Presentations – Day 2

Session 11 – Welcome

MC: Nathan Davis, Executive Director, MedReleaf Australia

Peter Crock, Chair, MCIA
Councillor Elizabeth Mary Doidge, City of Melbourne

Session 11 – Keynote Address

Keynote Address from Fiona Patten MP

Back to top

Session 12 – Industry and market outlook – John Penington

A look into the industry and market outlook, both here in Australia and overseas

Presenter:

• John Ryan, CEO, Penington Institute Findings from the Penington Institute Cannabis Report

Session 12 – Industry and market outlook – Andre Jerome

Presenter:

• Andre Jerome, EVP, Global Business Development, Aurora Global market opportunities

Back to top

Session 13 – Partnering for success in the medicinal cannabis industry

Moderator:

• Andrew Dowling, AltMed

Panel:

• Tyson Craig, Head of Business Development Wholesale Commercial, Greenship
• Aspa Dukas, Pharmacist and Founder, Dukasa Compounding
• Tommy Huppert, Founder and CEO, Cannatrek
• Mitchell Kurz, Co Founder, Phytoca Maverick Weller, CEO, GreenHaus Australia
• Melinda Thompson, SourceCertain

Back to top

Session 14 – Best-practices for medicinal cannabis prescribers & new education tools for healthcare practitioners

Moderator:

• Carol Ireland, CEO, Epilepsy Action Australia

Panel:

• Dr Orit Holtzman, Co Founder and Director, Functional & Cannabinoid Medicine Practitioner, Leura Wellness
• Stephane Kain, Service Development Manager, Epilepsy Action Australia
• Dr James Stewart
• Hugh Tait, Medical Services & Operations Manager, MedReleaf Australia

Back to top

Session 15 – Keynote address – John Easterling, Launch of the Olivia Newton-John Service to Industry Award

Moderator

• Peter Crock, Chair, MCIA

Keynote speaker

• John Easterling – Cannabis in Australia. What’s next

Back to top

Session 16 – Showcasing R&D and innovation – from plant to patient

An in-depth look at current status of plant research, the Endocannabinoid system, clinical trials and new medicine opportunities

Moderator:

Dr Peter Duggan, Senior Principal Research Scientist, CSIRO

Presenters:

• Associate Professor Monika S. Doblin, Research Director, ARC ITRH for Medicinal Agriculture, La Trobe University
  Overview of the cannabis research landscape in Australia
• Matt Hayes, PhD, Science Director, Triffid BioScience
  Cannabis genetics: status, risks and management for commercial production & breeding
• Dr Elizabeth Cairns, Research Fellow, Lambert Initiative for Cannabinoid Therapeutics, University of Sydney
  Preclincial models of disease & endocannabinoid system
• Dr Paul Wynne, Medicines Manufacturing Innovations Centre, Monash University
  From plant to patient – the drive for novelty in processing, purification, and formulation of cannabinoids
• Dr Amie Hayley, Rebecca L. Cooper Al and Val Rosenstrauss Fellow, Centre for Human Psychopharmacology, Swinburne University of Technology
  Driving trials/impairment detection and policy solutions

Back to top

Session 17 – Fireside chat with Cameron Scadding

How to achieve success while being ethical and legitimate

Moderator

• Nathan Davis, Executive Director, MedReleaf Australia

Speaker

• Cameron Scadding, CEO and Managing Director, Source Certain

Back to top

Session 18 – Wrap Up & Closing Comments

Back to top

Supplementary Video

Dr Kerryn Phelps, Hemp CRC
Role of evidence in expanding access to medicinal cannabis and building sustainable industries

Back to top